Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1996 | 06-1996 | 03-1996 | 12-1995 | 09-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,942 | 6,882 | 7,337 | 3,121 | N/A |
| Depreciation Amortization | 6,266 | 4,145 | 2,031 | 7,018 | N/A |
| Other Working Capital | -10,940 | 8,816 | 6,197 | 6,821 | N/A |
| Other Operating Activity | -38,037 | -26,615 | 3,095 | 11,737 | 0 |
| Operating Cash Flow | $-38,769 | $-6,772 | $18,660 | $28,697 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18,501 | -8,823 | -2,973 | -20,615 | N/A |
| Net Acquisitions | 261,752 | 0 | 261,752 | 0 | N/A |
| Other Investing Activity | -1,285 | 261,821 | 68 | -8,103 | 0 |
| Investing Cash Flow | $241,966 | $252,998 | $258,847 | $-28,718 | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -8,533 | -5,890 | -3,186 | -12,605 | N/A |
| Other Financing Activity | -193,802 | -167,490 | -125,863 | 12,925 | 0 |
| Financing Cash Flow | $-202,335 | $-173,380 | $-129,049 | $320 | $N/A |
| Beginning Cash Position | 629 | 629 | 629 | 330 | N/A |
| End Cash Position | 1,491 | 73,475 | 149,087 | 629 | N/A |
| Net Cash Flow | $862 | $72,846 | $148,458 | $299 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,769 | -6,772 | 18,660 | 28,697 | N/A |
| Free Cash Flow | -38,769 | -6,772 | 18,660 | 28,697 | 0 |